학술논문
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: A phase 1/2 trial
Document Type
Article
Author
Kennedy, G.A.; Varelias, A.; Vuckovic, S.; Le Texier, L.; Gartlan, K.H.; Zhang, P.; Boyle, G.; Cloonan, N.; Leach, J.; Sturgeon, E.; Avery, J.; Olver, S.D.; Lor, M.; MacDonald, K.P.A.; Tey, S.-K.; Hill, G.R.; Misra, A.K.; Hutchins, C.; Morton, A.J.; Durrant, S.T.S.; Subramoniapillai, E.; Butler, J.P.; Curley, C.I.; Thomas, G.; Anderson, L.
Source
In: The Lancet Oncology . (The Lancet Oncology, 2014, 15(13):1451-1459)
Subject
Language
English
ISSN
14745488
14702045
14702045